Management of Severe Mitral Stenosis
For severe mitral stenosis, percutaneous mitral balloon commissurotomy (PMBC) is the first-line intervention for symptomatic patients with favorable valve anatomy, while mitral valve surgery is indicated when PMBC is not feasible or appropriate. 1
Diagnosis and Assessment
Severe mitral stenosis is defined as:
- Mitral valve area (MVA) ≤1.0 cm²
- Diastolic pressure half-time ≥150 ms
- Mean transmitral pressure gradient ≥10 mmHg
- Severe left atrial enlargement 1
Critical distinction: Determine if the stenosis is:
Initial Medical Management
Symptom relief:
- Diuretics for pulmonary congestion and edema
- Careful diuresis to avoid hypotension 1
Heart rate control:
Anticoagulation:
- Vitamin K antagonists (VKAs) with target INR 2-3 for all patients with atrial fibrillation
- NOACs should NOT be used in mitral stenosis with atrial fibrillation
- For patients in sinus rhythm, oral anticoagulation is indicated with:
Interventional Management
Percutaneous Mitral Balloon Commissurotomy (PMBC)
Indications:
- First-line for symptomatic severe RMS with favorable valve anatomy
- Consider for asymptomatic severe RMS with:
Contraindications:
- Absence of commissural fusion (degenerative MS)
- Unfavorable valve morphology
- Left atrial thrombus
- More than mild mitral regurgitation 4
Surgical Intervention
Indications:
- Symptomatic severe MS when PMBC is not available or contraindicated
- Failed PMBC with persistent symptoms
- Concomitant need for other cardiac surgery
- Severe degenerative MS (as PMBC is ineffective) 4, 1
Options:
- Mitral valve repair (commissurotomy) if valve is suitable
- Mitral valve replacement when repair is not feasible 4
Special Populations and Scenarios
Pregnancy
- Medical therapy is first-line
- For symptomatic (NYHA III-IV) severe MS despite medical therapy, PMBC can be performed relatively safely
- Surgery carries significant risk to mother and fetus 4, 5
Elderly Patients
- PMBC is useful even if only palliative in elderly with rheumatic MS
- For degenerative MS with severely calcified annulus:
- Surgery is very high risk
- Transcatheter valve implantation may be considered in inoperable patients 4
Combined Valve Disease
- With severe aortic valve disease: Surgery is preferred if not contraindicated
- With moderate aortic valve disease: PMBC may postpone surgery for both valves
- With severe tricuspid regurgitation:
Follow-up and Monitoring
- Asymptomatic severe MS: Annual clinical and echocardiographic examinations
- Moderate MS: Follow-up every 2-3 years
- After successful PMBC: Similar to asymptomatic patients
- More frequent monitoring if asymptomatic restenosis occurs 4
Common Pitfalls to Avoid
Failing to distinguish between rheumatic and degenerative MS, as treatment approaches differ significantly 1
Delaying intervention in pregnancy, which can lead to maternal and fetal complications 1
Using NOACs instead of VKAs in mitral stenosis with atrial fibrillation 4
Attempting cardioversion before intervention in severe MS, as it does not durably restore sinus rhythm 4
Underestimating the importance of anticoagulation due to high risk of left atrial thrombus 1